Go to content
Esperite N.V.

Esperite N.V.

Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.

Publicatie datum 30 apr 2015 - 07:27
Statutaire naam Esperite N.V.
Titel ESPERITE (ESP) upgrades TRANQUILITY, the most complete CE-IVD marked fetal DNA NIPT that accurately detects Down syndrome and other chromosomal abnormalities
Bericht TRANQUILITY, the only CE-IVD certified genetic test for trisomies 21, 18 and 13 that provides, sexual aneuploidies, microdeletions and fetal sex detection, now ready for mass market Geneva, Switzerland - 30 April 2015 ESPERITE tops the trisomies detection market with TRANQUILITY: the CE-IVD marked and risk-free fetal DNA test that accurately detects Down syndrome (>99,9%), trisomies 18 and 13, sexual aneuploidies, microdeletions, and the sex of the baby, reporting results within 5 days. TRANQUILITY's entire testing process for trisomies (sample collection, preparation, sequencing, bioinformatics analysis and report) is compliant with the European In Vitro Diagnostics Medical Devices Directive 98/79/EC and has been certified by an independent body -UL International. TRANQUILITY combines the technologies of Iona and InKaryo, the recently acquired company now part of the ESPERITE group.

Datum laatste update: 29 juli 2024